Related references
Note: Only part of the references are listed.Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Ethan M. Basch et al.
EUROPEAN UROLOGY (2019)
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
O. Sartor et al.
ANNALS OF ONCOLOGY (2017)
Manipulating the Placebo Response in Experimental Pain by Altering Doctor's Performance Style
Efrat Czerniak et al.
FRONTIERS IN PSYCHOLOGY (2016)
Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013)
E. Vodicka et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Effect of radium-223 dichloride (Ra-223) on pain from US EAP.
Michael J. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC).
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pain Palliation Measurement in Cancer Clinical Trials
Ethan Basch et al.
CANCER (2014)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prevalence of Pain and Analgesic Use in Men With Metastatic Prostate Cancer Using a Patient-Reported Outcome Measure
Karen A. Autio et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
S. Nilsson et al.
EUROPEAN JOURNAL OF CANCER (2012)
The Brief Pain Inventory and Its Pain At Its Worst in the Last 24 Hours Item: Clinical Trial Endpoint Considerations
Thomas M. Atkinson et al.
PAIN MEDICINE (2010)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
RH Dworkin et al.
PAIN (2005)
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
JT Farrar et al.
PAIN (2001)
Share Paper
